A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis

被引:0
|
作者
C. Louapre
M. Rosenzwajg
M. Golse
A. Roux
F. Pitoiset
L. Adda
N. Tchitchek
C. Papeix
E. Maillart
A. Ungureanu
F. Charbonnier-Beaupel
D. Galanaud
J. C. Corvol
E. Vicaut
C. Lubetzki
D. Klatzmann
机构
[1] Sorbonne University,Neuroradiology Department
[2] Paris Brain Institute - ICM,undefined
[3] Assistance Publique Hôpitaux de Paris,undefined
[4] Inserm,undefined
[5] CNRS,undefined
[6] Hôpital de la Pitié Salpêtrière,undefined
[7] Department of Neurology,undefined
[8] CIC neurosciences,undefined
[9] Immunology-Immunopathology-Immunotherapy (i3)-UMRS_959,undefined
[10] Sorbonne Université- INSERM,undefined
[11] Assistance Publique Hôpitaux de Paris,undefined
[12] Hôpital Pitié-Salpêtrière,undefined
[13] Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD),undefined
[14] Assistance Publique Hôpitaux de Paris,undefined
[15] Hôpital Pitié-Salpêtrière,undefined
[16] Pharmacie à Usage Intérieur,undefined
[17] Reqpharm Unit,undefined
[18] Sorbonne University,undefined
[19] Assistance Publique Hôpitaux de Paris,undefined
[20] Assistance Publique Hôpitaux de Paris,undefined
[21] Lariboisière Hospital,undefined
[22] Clinical Trial Unit,undefined
来源
Journal of Neurology | 2023年 / 270卷
关键词
Neuroinflammation; Neurodegeneration; Immunoregulation; Immunosuppression; Tolerance; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4403 / 4414
页数:11
相关论文
共 50 条
  • [31] Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: clinical results from the randomized, double-blind, placebo-controlled trial
    Zhang, X.
    He, J.
    Zhang, R.
    Liu, X.
    Chen, J.
    Sun, X.
    Li, Z.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1852 - 1853
  • [32] A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis
    Coe, Shelly
    Cossington, Jo
    Collett, Johnny
    Soundy, Andrew
    Izadi, Hooshang
    Ovington, Martin
    Durkin, Luke
    Kirsten, Maja
    Clegg, Miriam
    Cavey, Ana
    Wade, Derick T.
    Palace, Jacqueline
    DeLuca, Gabriele C.
    Chapman, Kim
    Harrison, Jane-Marie
    Buckingham, Elizabeth
    Dawes, Helen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (05): : 507 - 513
  • [33] Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
    Gold, Ralf
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Havrdova, Eva
    Montalban, Xavier
    Radue, Ernst-Wilhelm
    Stefoski, Dusan
    Robinson, Randy
    Riester, Katherine
    Rana, Jitesh
    Elkins, Jacob
    O'Neill, Gilmore
    LANCET, 2013, 381 (9884): : 2167 - 2175
  • [34] A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
    Knobler, RM
    French, LE
    Kim, Y
    Bisaccia, E
    Graninger, W
    Nahavandi, H
    Strobl, FJ
    Keystone, E
    Mehlmauer, M
    Rook, AH
    Braverman, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (05) : 793 - 799
  • [35] A Double-Blind, Randomized, Placebo-Controlled Trial of Simvastatin as Add-On Therapy to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Sorensen, Per Soelberg
    Lycke, Jan
    Eralinna, Juha-Pekka
    Edland, Astrid
    Wu, Xingchen
    Frederiksen, Jette L.
    Oturai, Annette Bang
    Malmestrom, Clas
    Stenager, Egon
    Sperling, Bjorn
    NEUROLOGY, 2011, 76 (09) : A546 - A547
  • [36] A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis
    Wenham, Claire Y. J.
    Hensor, Elizabeth M. A.
    Grainger, Andrew J.
    Hodgson, Richard
    Balamoody, Sharon
    Dore, Caroline J.
    Emery, Paul
    Conaghan, Philip G.
    RHEUMATOLOGY, 2012, 51 (12) : 2286 - 2294
  • [37] Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole - A randomized, double-blind, placebo-controlled trial
    Robinson, M
    Lanza, F
    Avner, D
    Haber, M
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) : 859 - +
  • [38] Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
    Fava, Maurizio
    Durgam, Suresh
    Earley, Willie
    Lu, Kaifeng
    Hayes, Robert
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (06) : 312 - 321
  • [39] Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial
    Harada, Tasuku
    Momoeda, Mikio
    Terakawa, Naoki
    Taketani, Yuji
    Hoshiai, Hiroshi
    FERTILITY AND STERILITY, 2011, 95 (06) : 1928 - 1931
  • [40] Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies
    Milito, Cinzia
    Pulvirenti, Federica
    Cinetto, Francesco
    Lougaris, Vassilios
    Soresina, Annarosa
    Pecoraro, Antonio
    Vultaggio, Alessandra
    Carrabba, Maria
    Lassandro, Giuseppe
    Plebani, Alessandro
    Spadaro, Giuseppe
    Matucci, Andrea
    Fabio, Giovanna
    Dellepiane, Rosa Maria
    Martire, Baldassarre
    Agostini, Carlo
    Abeni, Damiano
    Tabolli, Stefano
    Quinti, Isabella
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 584 - +